BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou F. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation. Int Rev Immunol 2009;28:239-60. [PMID: 19811323 DOI: 10.1080/08830180902978120] [Cited by in Crossref: 160] [Cited by in F6Publishing: 157] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Moore EC, Cash HA, Caruso AM, Uppaluri R, Hodge JW, Van Waes C, Allen CT. Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers. Cancer Immunol Res 2016;4:611-20. [PMID: 27076449 DOI: 10.1158/2326-6066.CIR-15-0252] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
2 Wu M, Fu P, Qu L, Liu J, Lin A. Long Noncoding RNAs, New Critical Regulators in Cancer Immunity. Front Oncol 2020;10:550987. [PMID: 33194608 DOI: 10.3389/fonc.2020.550987] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
3 Thomas S, Klobuch S, Podlech J, Plachter B, Hoffmann P, Renzaho A, Theobald M, Reddehase MJ, Herr W, Lemmermann NA. Evaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice. PLoS Pathog 2015;11:e1005049. [PMID: 26181057 DOI: 10.1371/journal.ppat.1005049] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
4 Chong C, Marino F, Pak H, Racle J, Daniel RT, Müller M, Gfeller D, Coukos G, Bassani-Sternberg M. High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome. Mol Cell Proteomics 2018;17:533-48. [PMID: 29242379 DOI: 10.1074/mcp.TIR117.000383] [Cited by in Crossref: 84] [Cited by in F6Publishing: 45] [Article Influence: 16.8] [Reference Citation Analysis]
5 Hansen TR, Smirnova NP, Webb BT, Bielefeldt-Ohmann H, Sacco RE, Van Campen H. Innate and adaptive immune responses to in utero infection with bovine viral diarrhea virus. Anim Health Res Rev 2015;16:15-26. [PMID: 26050568 DOI: 10.1017/S1466252315000122] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
6 Ward AB, Keeton AB, Chen X, Mattox TE, Coley AB, Maxuitenko YY, Buchsbaum DJ, Randall TD, Zhou G, Piazza GA. Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS. MedComm (Beijing) 2020;1:121-8. [PMID: 33073260 DOI: 10.1002/mco2.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Abreu R, Giri P, Quinn F. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis. Front Immunol 2020;11:1553. [PMID: 32849525 DOI: 10.3389/fimmu.2020.01553] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Wang HF, Wang SS, Huang MC, Liang XH, Tang YJ, Tang YL. Targeting Immune-Mediated Dormancy: A Promising Treatment of Cancer. Front Oncol 2019;9:498. [PMID: 31297335 DOI: 10.3389/fonc.2019.00498] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
9 Shen J, Li ZJ, Li LF, Lu L, Xiao ZG, Wu WK, Zhang L, Li MX, Hu W, Chan KM, Cho CH. Vascular-targeted TNFα and IFNγ inhibits orthotopic colorectal tumor growth. J Transl Med 2016;14:187. [PMID: 27342639 DOI: 10.1186/s12967-016-0944-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
10 Mertens J, Ramadori G, Mihm S. Functional relevance of the IRF-1 promoter polymorphism rs2549009 on transcriptional activity in a native genomic environment. Hum Mol Genet 2010;19:4587-94. [PMID: 20846942 DOI: 10.1093/hmg/ddq386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
11 Chaurasiya SK. Tuberculosis: Smart manipulation of a lethal host. Microbiol Immunol 2018;62:361-79. [PMID: 29687912 DOI: 10.1111/1348-0421.12593] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
12 Pettengill MA, van Haren SD, Levy O. Soluble mediators regulating immunity in early life. Front Immunol 2014;5:457. [PMID: 25309541 DOI: 10.3389/fimmu.2014.00457] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
13 Luo N, Nixon MJ, Gonzalez-Ericsson PI, Sanchez V, Opalenik SR, Li H, Zahnow CA, Nickels ML, Liu F, Tantawy MN, Sanders ME, Manning HC, Balko JM. DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer. Nat Commun. 2018;9:248. [PMID: 29339738 DOI: 10.1038/s41467-017-02630-w] [Cited by in Crossref: 67] [Cited by in F6Publishing: 73] [Article Influence: 16.8] [Reference Citation Analysis]
14 Shalapour S, Karin M. The neglected brothers come of age: B cells and cancer. Semin Immunol 2021;:101479. [PMID: 34215491 DOI: 10.1016/j.smim.2021.101479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Li B, Chen A, Zou S, Wu J, Wang H, Chen R, Luo M. Albumin fusion improves the pharmacokinetics and in vivo antitumor efficacy of canine interferon gamma. International Journal of Pharmaceutics 2019;558:404-12. [DOI: 10.1016/j.ijpharm.2018.12.081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Damrauer SM, Studer P, da Silva CG, Longo CR, Ramsey HE, Csizmadia E, Shrikhande GV, Scali ST, Libermann TA, Bhasin MK, Ferran C. A20 modulates lipid metabolism and energy production to promote liver regeneration. PLoS One 2011;6:e17715. [PMID: 21437236 DOI: 10.1371/journal.pone.0017715] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
17 Horras CJ, Lamb CL, Mitchell KA. Regulation of hepatocyte fate by interferon-γ. Cytokine Growth Factor Rev 2011;22:35-43. [PMID: 21334249 DOI: 10.1016/j.cytogfr.2011.01.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 5.8] [Reference Citation Analysis]
18 Perona-Wright G, Mohrs K, Mohrs M. Sustained signaling by canonical helper T cell cytokines throughout the reactive lymph node. Nat Immunol 2010;11:520-6. [PMID: 20418876 DOI: 10.1038/ni.1866] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 6.4] [Reference Citation Analysis]
19 Suarez GV, Angerami MT, Vecchione MB, Laufer N, Turk G, Ruiz MJ, Mesch V, Fabre B, Maidana P, Ameri D, Cahn P, Sued O, Salomón H, Bottasso OA, Quiroga MF. HIV-TB coinfection impairs CD8(+) T-cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses. Eur J Immunol 2015;45:2529-41. [PMID: 26047476 DOI: 10.1002/eji.201545545] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
20 Natale NR, Lukens JR, Petri WA Jr. The nervous system during COVID-19: Caught in the crossfire. Immunol Rev 2022. [PMID: 35770683 DOI: 10.1111/imr.13114] [Reference Citation Analysis]
21 Shen Y, Wei X, Jin S, Wu Y, Zhao W, Xu Y, Pan L, Zhou Z, Chen S. TCR-mimic antibody-drug conjugates targeting intracellular tumor-specific mutant antigen KRAS G12V mutation. Asian J Pharm Sci 2020;15:777-85. [PMID: 33363632 DOI: 10.1016/j.ajps.2020.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 van Vloten JP, Santry LA, McAusland TM, Karimi K, McFadden G, Petrik JJ, Wootton SK, Bridle BW. Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies. Mol Ther Methods Clin Dev 2019;13:154-66. [PMID: 30788384 DOI: 10.1016/j.omtm.2019.01.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
23 Wang CI, Chang YF, Sie ZL, Ho AS, Chang JS, Peng CL, Cheng CC. Irradiation Suppresses IFNγ-Mediated PD-L1 and MCL1 Expression in EGFR-Positive Lung Cancer to Augment CD8+ T Cells Cytotoxicity. Cells 2021;10:2515. [PMID: 34685495 DOI: 10.3390/cells10102515] [Reference Citation Analysis]
24 Hojo-Souza NS, de Azevedo PO, de Castro JT, Teixeira-Carvalho A, Lieberman J, Junqueira C, Gazzinelli RT. Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage. PLoS Pathog 2020;16:e1008840. [PMID: 32913355 DOI: 10.1371/journal.ppat.1008840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yu Z, Cao W, Gao X, Aleem MT, Liu J, Luo J, Yan R, Xu L, Song X, Li X. With Chitosan and PLGA as the Delivery Vehicle, Toxoplasma gondii Oxidoreductase-Based DNA Vaccines Decrease Parasite Burdens in Mice. Front Immunol 2021;12:726615. [PMID: 34512659 DOI: 10.3389/fimmu.2021.726615] [Reference Citation Analysis]
26 Faje AT, Lawrence D, Flaherty K, Freedman C, Fadden R, Rubin K, Cohen J, Sullivan RJ. High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma. Cancer 2018;124:3706-14. [PMID: 29975414 DOI: 10.1002/cncr.31629] [Cited by in Crossref: 159] [Cited by in F6Publishing: 145] [Article Influence: 39.8] [Reference Citation Analysis]
27 Quinn CH, Beierle AM, Hutchins SC, Marayati R, Bownes LV, Stewart JE, Markert HR, Erwin MH, Aye JM, Yoon KJ, Friedman GK, Willey CD, Markert JM, Beierle EA. Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy. Cancers (Basel) 2022;14:762. [PMID: 35159029 DOI: 10.3390/cancers14030762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Harms JS, Khan M, Hall C, Splitter GA, Homan EJ, Bremel RD, Smith JA. Brucella Peptide Cross-Reactive Major Histocompatibility Complex Class I Presentation Activates SIINFEKL-Specific T Cell Receptor-Expressing T Cells. Infect Immun 2018;86:e00281-18. [PMID: 29735518 DOI: 10.1128/IAI.00281-18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
29 Jameson JM, Cruz J, Costanzo A, Terajima M, Ennis FA. A role for the mevalonate pathway in the induction of subtype cross-reactive immunity to influenza A virus by human gammadelta T lymphocytes. Cell Immunol 2010;264:71-7. [PMID: 20483407 DOI: 10.1016/j.cellimm.2010.04.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
30 Sabbatino F, Liguori L, Polcaro G, Salvato I, Caramori G, Salzano FA, Casolaro V, Stellato C, Col JD, Pepe S. Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients. Int J Mol Sci 2020;21:E7295. [PMID: 33023239 DOI: 10.3390/ijms21197295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
31 Barrionuevo P, Delpino MV, Pozner RG, Velásquez LN, Cassataro J, Giambartolomei GH. Brucella abortus induces intracellular retention of MHC-I molecules in human macrophages down-modulating cytotoxic CD8(+) T cell responses. Cell Microbiol 2013;15:487-502. [PMID: 23107169 DOI: 10.1111/cmi.12058] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
32 Komov L, Kadosh DM, Barnea E, Milner E, Hendler A, Admon A. Cell Surface MHC Class I Expression Is Limited by the Availability of Peptide-Receptive "Empty" Molecules Rather than by the Supply of Peptide Ligands. Proteomics 2018;18:e1700248. [PMID: 29707912 DOI: 10.1002/pmic.201700248] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
33 Yu Z, He K, Cao W, Aleem MT, Yan R, Xu L, Song X, Li X. Nano vaccines for T. gondii Ribosomal P2 Protein With Nanomaterials as a Promising DNA Vaccine Against Toxoplasmosis. Front Immunol 2022;13:839489. [PMID: 35265084 DOI: 10.3389/fimmu.2022.839489] [Reference Citation Analysis]
34 [DOI: 10.1101/351353] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
35 Liu W, Lien YH, Lee PI, Chan TC, Wang LC, Yang CR, Ho MS, Chen JR, Ku CC, King CC. Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health. Vaccine 2022:S0264-410X(22)00358-9. [PMID: 35525727 DOI: 10.1016/j.vaccine.2022.03.047] [Reference Citation Analysis]
36 Lee H, Da Silva IP, Palendira U, Scolyer RA, Long GV, Wilmott JS. Targeting NK Cells to Enhance Melanoma Response to Immunotherapies. Cancers (Basel) 2021;13:1363. [PMID: 33802954 DOI: 10.3390/cancers13061363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Arellano-Garcia ME, Misuno K, Tran SD, Hu S. Interferon-γ induces immunoproteasomes and the presentation of MHC I-associated peptides on human salivary gland cells. PLoS One 2014;9:e102878. [PMID: 25102056 DOI: 10.1371/journal.pone.0102878] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
38 Tretina K, Gotia HT, Mann DJ, Silva JC. Theileria-transformed bovine leukocytes have cancer hallmarks. Trends in Parasitology 2015;31:306-14. [DOI: 10.1016/j.pt.2015.04.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 8.7] [Reference Citation Analysis]
39 Glassman CR, Mathiharan YK, Jude KM, Su L, Panova O, Lupardus PJ, Spangler JB, Ely LK, Thomas C, Skiniotis G, Garcia KC. Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells. Cell 2021;184:983-999.e24. [PMID: 33606986 DOI: 10.1016/j.cell.2021.01.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
40 Paget C, Chow MT, Duret H, Mattarollo SR, Smyth MJ. Role of γδ T cells in α-galactosylceramide-mediated immunity. J Immunol 2012;188:3928-39. [PMID: 22412194 DOI: 10.4049/jimmunol.1103582] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
41 Goncalves G, Mullan KA, Duscharla D, Ayala R, Croft NP, Faridi P, Purcell AW. IFNγ Modulates the Immunopeptidome of Triple Negative Breast Cancer Cells by Enhancing and Diversifying Antigen Processing and Presentation. Front Immunol 2021;12:645770. [PMID: 33968037 DOI: 10.3389/fimmu.2021.645770] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
42 Hanke NT, LaCasse CJ, Larmonier CB, Alizadeh D, Trad M, Janikashvili N, Bonnotte B, Katsanis E, Larmonier N. PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15. Eur J Immunol 2014;44:2489-99. [PMID: 24777831 DOI: 10.1002/eji.201343803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
43 Aqbi HF, Wallace M, Sappal S, Payne KK, Manjili MH. IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression. J Leukoc Biol 2018. [PMID: 29469956 DOI: 10.1002/JLB.5MIR0917-351R] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
44 Shimizu K, Sugiura D, Okazaki IM, Maruhashi T, Takemoto T, Okazaki T. PD-1 preferentially inhibits the activation of low-affinity T cells. Proc Natl Acad Sci U S A 2021;118:e2107141118. [PMID: 34433672 DOI: 10.1073/pnas.2107141118] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Kors S, Geijtenbeek K, Reits E, Schipper-Krom S. Regulation of Proteasome Activity by (Post-)transcriptional Mechanisms. Front Mol Biosci 2019;6:48. [PMID: 31380390 DOI: 10.3389/fmolb.2019.00048] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
46 Zhang W, Shi F, Kong Y, Li Y, Sheng C, Wang S, Wang Q. Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non-small cell lung cancer. Cancer Med 2021. [PMID: 34862763 DOI: 10.1002/cam4.4472] [Reference Citation Analysis]
47 González-Pastor R, Ashshi AM, El-Shemi AG, Dmitriev IP, Kashentseva EA, Lu ZH, Goedegebuure SP, Podhajcer OL, Curiel DT. Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents. J Ovarian Res 2019;12:18. [PMID: 30767772 DOI: 10.1186/s13048-019-0493-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Wang S, Wang Y, Sun X, Zhang Z, Liu T, Gadahi JA, Xu L, Yan R, Song X, Li X. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii 10 kDa excretory-secretory antigen (TgESA10). Vet Parasitol 2015;214:40-8. [PMID: 26421596 DOI: 10.1016/j.vetpar.2015.09.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
49 Ye Z, Qian Q, Jin H, Qian Q. Cancer vaccine: learning lessons from immune checkpoint inhibitors. J Cancer 2018;9:263-8. [PMID: 29344272 DOI: 10.7150/jca.20059] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
50 Dhatchinamoorthy K, Colbert JD, Rock KL. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Front Immunol 2021;12:636568. [PMID: 33767702 DOI: 10.3389/fimmu.2021.636568] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
51 Zhang H, Zhang T, Wang D, Jiang Y, Guo T, Zhang Y, Zhu F, Han K, Mu L, Wang G. IFN-γ regulates the transformation of microglia into dendritic-like cells via the ERK/c-myc signaling pathway during cerebral ischemia/reperfusion in mice. Neurochemistry International 2020;141:104860. [DOI: 10.1016/j.neuint.2020.104860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Zheng X, Luo Y, Li Q, Feng J, Zhao C, Lu J, Luo J, Zhang J. Two Gene Set Variation Index as Biomarker of Bacterial and Fungal Sepsis. Biomed Res Int 2020;2020:8182358. [PMID: 32596378 DOI: 10.1155/2020/8182358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Zhao WB, Shen Y, Liu WH, Li YM, Jin SJ, Xu YC, Pan LQ, Zhou Z, Chen SQ. Soluble Expression of Fc-Fused T Cell Receptors Allows Yielding Novel Bispecific T Cell Engagers. Biomedicines 2021;9:790. [PMID: 34356854 DOI: 10.3390/biomedicines9070790] [Reference Citation Analysis]
54 Valentinuzzi D, Simončič U, Uršič K, Vrankar M, Turk M, Jeraj R. Predicting tumour response to anti-PD-1 immunotherapy with computational modelling. Phys Med Biol 2019;64:025017. [DOI: 10.1088/1361-6560/aaf96c] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
55 Hu ZJ, Xu J, Yin JM, Li L, Hou W, Zhang LL, Zhou Z, Yu YZ, Li HJ, Feng YM, Jin RH. Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients. Front Immunol 2020;11:585647. [PMID: 33133104 DOI: 10.3389/fimmu.2020.585647] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
56 Gonzalez OA, Novak MJ, Kirakodu S, Orraca L, Chen KC, Stromberg A, Gonzalez-Martinez J, Ebersole JL. Comparative analysis of gingival tissue antigen presentation pathways in ageing and periodontitis. J Clin Periodontol 2014;41:327-39. [PMID: 24304139 DOI: 10.1111/jcpe.12212] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
57 Imai T, Suzue K, Ngo-Thanh H, Ono S, Orita W, Suzuki H, Shimokawa C, Olia A, Obi S, Taniguchi T, Ishida H, Van Kaer L, Murata S, Tanaka K, Hisaeda H. Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria Plasmodium yoelii. Front Immunol 2019;10:2207. [PMID: 31608052 DOI: 10.3389/fimmu.2019.02207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
58 Stachyra K, Dudzisz-Śledź M, Bylina E, Szumera-Ciećkiewicz A, Spałek MJ, Bartnik E, Rutkowski P, Czarnecka AM. Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies. Int J Mol Sci 2021;22:6305. [PMID: 34208339 DOI: 10.3390/ijms22126305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Yu WD, Wang H, He QF, Xu Y, Wang XC. Long noncoding RNAs in cancer-immunity cycle. J Cell Physiol. 2018;233:6518-6523. [PMID: 29574911 DOI: 10.1002/jcp.26568] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 11.8] [Reference Citation Analysis]
60 Shalapour S, Karin M. Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation. Immunity. 2019;51:15-26. [PMID: 31315033 DOI: 10.1016/j.immuni.2019.06.021] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 19.0] [Reference Citation Analysis]
61 Friedrich M, Jasinski-Bergner S, Lazaridou MF, Subbarayan K, Massa C, Tretbar S, Mueller A, Handke D, Biehl K, Bukur J, Donia M, Mandelboim O, Seliger B. Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy. Cancer Immunol Immunother 2019;68:1689-700. [PMID: 31375885 DOI: 10.1007/s00262-019-02373-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 11.7] [Reference Citation Analysis]
62 Fink A, Lemmermann NA, Gillert-Marien D, Thomas D, Freitag K, Böhm V, Wilhelmi V, Reifenberg K, Reddehase MJ, Holtappels R. Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells. Med Microbiol Immunol 2012;201:513-25. [PMID: 22961126 DOI: 10.1007/s00430-012-0256-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
63 Kulski JK. Long Noncoding RNA HCP5, a Hybrid HLA Class I Endogenous Retroviral Gene: Structure, Expression, and Disease Associations. Cells 2019;8:E480. [PMID: 31137555 DOI: 10.3390/cells8050480] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
64 Tripathi SC, Vedpathak D, Ostrin EJ. The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer. Cells 2021;10:3587. [PMID: 34944095 DOI: 10.3390/cells10123587] [Reference Citation Analysis]
65 Dou S, Li R, He N, Zhang M, Jiang W, Ye L, Yang Y, Zhao G, Yang Y, Li J, Chen D, Zhu G. The Immune Landscape of Chinese Head and Neck Adenoid Cystic Carcinoma and Clinical Implication. Front Immunol 2021;12:618367. [PMID: 34552580 DOI: 10.3389/fimmu.2021.618367] [Reference Citation Analysis]
66 Papale M. A Review of Proteomics Strategies to Study T-Cell Activation and Function in Cancer Disease. Methods Mol Biol 2021;2325:125-36. [PMID: 34053055 DOI: 10.1007/978-1-0716-1507-2_9] [Reference Citation Analysis]
67 Stege H, Haist M, Nikfarjam U, Schultheis M, Heinz J, Pemler S, Loquai C, Grabbe S. The Status of Adjuvant and Neoadjuvant Melanoma Therapy, New Developments and Upcoming Challenges. Target Oncol 2021;16:537-52. [PMID: 34554353 DOI: 10.1007/s11523-021-00840-3] [Reference Citation Analysis]
68 Naglak EK, Morrison SG, Morrison RP. IFNγ is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection. Infect Immun 2016;84:3232-42. [PMID: 27600502 DOI: 10.1128/IAI.00749-16] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
69 Lattanzi L, Rozera C, Marescotti D, D'Agostino G, Santodonato L, Cellini S, Belardelli F, Gavioli R, Ferrantini M. IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity. Immunobiology 2011;216:537-47. [PMID: 21093097 DOI: 10.1016/j.imbio.2010.10.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
70 Chong C, Müller M, Pak H, Harnett D, Huber F, Grun D, Leleu M, Auger A, Arnaud M, Stevenson BJ, Michaux J, Bilic I, Hirsekorn A, Calviello L, Simó-Riudalbas L, Planet E, Lubiński J, Bryśkiewicz M, Wiznerowicz M, Xenarios I, Zhang L, Trono D, Harari A, Ohler U, Coukos G, Bassani-Sternberg M. Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes. Nat Commun 2020;11:1293. [PMID: 32157095 DOI: 10.1038/s41467-020-14968-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 21.5] [Reference Citation Analysis]
71 Fan J, Shen X, Wang Y, Zhou HL, Liu G, Li YL, Xu ZX. Biomarkers for immune checkpoint therapy targeting programmed death 1 and programmed death ligand 1. Biomed Pharmacother 2020;130:110621. [PMID: 34321165 DOI: 10.1016/j.biopha.2020.110621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
72 Asleh K, Negri GL, Spencer Miko SE, Colborne S, Hughes CS, Wang XQ, Gao D, Gilks CB, Chia SKL, Nielsen TO, Morin GB. Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes. Nat Commun 2022;13:896. [PMID: 35173148 DOI: 10.1038/s41467-022-28524-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
73 Stutvoet TS, Kol A, de Vries EG, de Bruyn M, Fehrmann RS, Terwisscha van Scheltinga AG, de Jong S. MAPK pathway activity plays a key role in PD-L1 expression of lung adenocarcinoma cells. J Pathol 2019;249:52-64. [PMID: 30972766 DOI: 10.1002/path.5280] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
74 Sheffer M, Lowry E, Beelen N, Borah M, Amara SN, Mader CC, Roth JA, Tsherniak A, Freeman SS, Dashevsky O, Gandolfi S, Bender S, Bryan JG, Zhu C, Wang L, Tariq I, Kamath GM, Simoes RM, Dhimolea E, Yu C, Hu Y, Dufva O, Giannakis M, Syrgkanis V, Fraenkel E, Golub T, Romee R, Mustjoki S, Culhane AC, Wieten L, Mitsiades CS. Genome-scale screens identify factors regulating tumor cell responses to natural killer cells. Nat Genet 2021;53:1196-206. [PMID: 34253920 DOI: 10.1038/s41588-021-00889-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Poli A, Michel T, Patil N, Zimmer J. Revisiting the Functional Impact of NK Cells. Trends Immunol 2018;39:460-72. [PMID: 29496432 DOI: 10.1016/j.it.2018.01.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
76 Yu JA, Lee JY, Kim TY, Kang H, Lee SY, Mitiku H, Park J, Lee YH, Chang HB, Lee BH, Lee K, Apostolidis E, Kwon YI. Immune Modulatory Activities of Arginyl-Fructose (AF) and AF-Enriched Natural Products in In-Vitro and In-Vivo Animal Models. Molecules 2021;26:2251. [PMID: 33924652 DOI: 10.3390/molecules26082251] [Reference Citation Analysis]
77 Cui D, Wang J, Zeng Y, Rao L, Chen H, Li W, Li Y, Li H, Cui C, Xiao L. Generating hESCs with reduced immunogenicity by disrupting TAP1 or TAPBP. Biosci Biotechnol Biochem 2016;80:1484-91. [PMID: 27068360 DOI: 10.1080/09168451.2016.1165601] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
78 Sobue A, Ito N, Nagai T, Shan W, Hada K, Nakajima A, Murakami Y, Mouri A, Yamamoto Y, Nabeshima T, Saito K, Yamada K. Astroglial major histocompatibility complex class I following immune activation leads to behavioral and neuropathological changes. Glia 2018;66:1034-52. [PMID: 29380419 DOI: 10.1002/glia.23299] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
79 Ke M, Wang H, Zhang M, Tian Y, Wang Y, Li B, Yu J, Dou J, Xi T, Zhou C. The anti-lung cancer activity of SEP is mediated by the activation and cytotoxicity of NK cells via TLR2/4 in vivo. Biochem Pharmacol 2014;89:119-30. [PMID: 24630931 DOI: 10.1016/j.bcp.2014.02.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
80 Stifter K, Krieger J, Ruths L, Gout J, Mulaw M, Lechel A, Kleger A, Seufferlein T, Wagner M, Schirmbeck R. IFN-γ treatment protocol for MHC-Ilo/PD-L1+ pancreatic tumor cells selectively restores their TAP-mediated presentation competence and CD8 T-cell priming potential. J Immunother Cancer 2020;8:e000692. [PMID: 32868392 DOI: 10.1136/jitc-2020-000692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Strumillo ST, Kartavykh D, de Carvalho FF Jr, Cruz NC, de Souza Teodoro AC, Sobhie Diaz R, Curcio MF. Host-virus interaction and viral evasion. Cell Biol Int 2021;45:1124-47. [PMID: 33533523 DOI: 10.1002/cbin.11565] [Reference Citation Analysis]
82 Otsuka A, Levesque MP, Dummer R, Kabashima K. Hedgehog signaling in basal cell carcinoma. J Dermatol Sci 2015;78:95-100. [PMID: 25766766 DOI: 10.1016/j.jdermsci.2015.02.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
83 Akkad N, Schatz M, Dengjel J, Tenzer S, Schild H. Census of cytosolic aminopeptidase activity reveals two novel cytosolic aminopeptidases. Med Microbiol Immunol 2012;201:463-73. [DOI: 10.1007/s00430-012-0266-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
84 Rosales-Reyes R, Garza-Villafuerte P, Vences-Vences D, Aubert DF, Aca-Teutle R, Ortiz-Navarrete VF, Bonifaz LC, Carrero-Sánchez JC, Olivos-García A, Valvano MA, Santos-Preciado JI. Interferon-gamma-activated macrophages infected with Burkholderia cenocepacia process and present bacterial antigens to T-cells by class I and II major histocompatibility complex molecules. Emerg Microbes Infect 2020;9:2000-12. [PMID: 32873215 DOI: 10.1080/22221751.2020.1818632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
85 Meissl K, Simonović N, Amenitsch L, Witalisz-Siepracka A, Klein K, Lassnig C, Puga A, Vogl C, Poelzl A, Bosmann M, Dohnal A, Sexl V, Müller M, Strobl B. STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity. Front Immunol 2020;11:2189. [PMID: 33042133 DOI: 10.3389/fimmu.2020.02189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Jiang H, Clise-Dwyer K, Ruisaard KE, Fan X, Tian W, Gumin J, Lamfers ML, Kleijn A, Lang FF, Yung WK, Vence LM, Gomez-Manzano C, Fueyo J. Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model. PLoS One 2014;9:e97407. [PMID: 24827739 DOI: 10.1371/journal.pone.0097407] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 9.0] [Reference Citation Analysis]
87 Namkoong E, Lee SW, Kim N, Choi Y, Park K. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome. Mol Immunol 2017;90:136-42. [PMID: 28750255 DOI: 10.1016/j.molimm.2017.07.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
88 Shen Y, Li YM, Zhou JJ, Zhou Z, Xu YC, Zhao WB, Chen SQ. The Antitumor Activity of TCR-Mimic Antibody-Drug Conjugates (TCRm-ADCs) Targeting the Intracellular Wilms Tumor 1 (WT1) Oncoprotein. Int J Mol Sci 2019;20:E3912. [PMID: 31408937 DOI: 10.3390/ijms20163912] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
89 Kiritsy MC, Ankley LM, Trombley J, Huizinga GP, Lord AE, Orning P, Elling R, Fitzgerald KA, Olive AJ. A genetic screen in macrophages identifies new regulators of IFNγ-inducible MHCII that contribute to T cell activation. Elife 2021;10:e65110. [PMID: 34747695 DOI: 10.7554/eLife.65110] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Sivaram N, McLaughlin PA, Han HV, Petrenko O, Jiang YP, Ballou LM, Pham K, Liu C, van der Velden AW, Lin RZ. Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer. J Clin Invest 2019;129:3264-76. [PMID: 31112530 DOI: 10.1172/JCI123540] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 6.7] [Reference Citation Analysis]
91 Levy ES, Chang R, Zamecnik CR, Dhariwala MO, Fong L, Desai TA. Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor Immunity. Mol Pharm 2021;18:1014-25. [PMID: 33541072 DOI: 10.1021/acs.molpharmaceut.0c00984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
92 Gao A, Gupta S, Shi H, Liu Y, Schroder AL, Witting PK, Ahmad G. Pro-Inflammatory Serum Amyloid a Stimulates Renal Dysfunction and Enhances Atherosclerosis in Apo E-Deficient Mice. Int J Mol Sci 2021;22:12582. [PMID: 34830462 DOI: 10.3390/ijms222212582] [Reference Citation Analysis]
93 Tu C, Bu Y, Vujcic M, Shen S, Li J, Qu M, Hangauer D, Clements JL, Qu J. Ion Current-Based Proteomic Profiling for Understanding the Inhibitory Effect of Tumor Necrosis Factor Alpha on Myogenic Differentiation. J Proteome Res 2016;15:3147-57. [PMID: 27480135 DOI: 10.1021/acs.jproteome.6b00321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
94 Daza J, Charap A, Wiklund PN, Sfakianos JP. Role of the Innate Immune System in the Development, Progression, and Therapeutic Response of Bladder Cancer. Eur Urol Focus 2020;6:650-2. [PMID: 32111511 DOI: 10.1016/j.euf.2020.02.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Ashshi AM, El-Shemi AG, Dmitriev IP, Kashentseva EA, Curiel DT. Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer. J Ovarian Res 2016;9:38. [PMID: 27349517 DOI: 10.1186/s13048-016-0248-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
96 Herr W, Eichinger Y, Beshay J, Bloetz A, Vatter S, Mirbeth C, Distler E, Hartwig UF, Thomas S. HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation. Leukemia 2017;31:434-45. [DOI: 10.1038/leu.2016.210] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
97 Wang L, Liu H, Chen X, Zhang M, Xie K, Ma Q. Immune sculpting of norepinephrine on MHC-I, B7-1, IDO and B7-H1 expression and regulation of proliferation and invasion in pancreatic carcinoma cells. PLoS One 2012;7:e45491. [PMID: 23029049 DOI: 10.1371/journal.pone.0045491] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
98 Zhao Y, Cao Y, Chen Y, Wu L, Hang H, Jiang C, Zhou X. B2M gene expression shapes the immune landscape of lung adenocarcinoma and determines the response to immunotherapy. Immunology 2021. [PMID: 34115389 DOI: 10.1111/imm.13384] [Reference Citation Analysis]
99 Olson MR, Russ BE, Doherty PC, Turner SJ. The role of epigenetics in the acquisition and maintenance of effector function in virus-specific CD8 T cells. IUBMB Life 2010;62:519-26. [PMID: 20552633 DOI: 10.1002/iub.351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
100 Yeo JG, Leong JY, Tay SH, Nadua KD, Anderson DE, Lim AJM, Ng XW, Poh SL, Guo D, Yaung KN, Kumar P, Wasser M, Hazirah SN, Sutamam N, Chua CJH, Qui M, Foo R, Gamage AM, Yeo KT, Ramakrishna L, Arkachaisri T, Young BE, Lye DC, Wang LF, Chong CY, Tan NWH, Li J, Kam KQ, Ginhoux F, Thoon KC, Chan JKY, Yung CF, Albani S. A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19. Front Immunol 2021;12:674279. [PMID: 34113347 DOI: 10.3389/fimmu.2021.674279] [Reference Citation Analysis]
101 Scheinman RI, Trivedi R, Vermillion S, Kompella UB. Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model. Nanomedicine (Lond) 2011;6:1669-82. [PMID: 22087799 DOI: 10.2217/nnm.11.90] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
102 Khan MA, Malik A, Alruwetei A, Alzohairy MA, Alhatlani BY, Al Rugaie O, Alhumaydhi FA, Khan A. Delivery of MERS antigen encapsulated in α-GalCer-bearing liposomes elicits stronger antigen-specific immune responses. J Drug Target 2022;:1-15. [PMID: 35418263 DOI: 10.1080/1061186X.2022.2066681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Falcomatà C, Bärthel S, Widholz SA, Schneeweis C, Montero JJ, Toska A, Mir J, Kaltenbacher T, Heetmeyer J, Swietlik JJ, Cheng JY, Teodorescu B, Reichert O, Schmitt C, Grabichler K, Coluccio A, Boniolo F, Veltkamp C, Zukowska M, Vargas AA, Paik WH, Jesinghaus M, Steiger K, Maresch R, Öllinger R, Ammon T, Baranov O, Robles MS, Rechenberger J, Kuster B, Meissner F, Reichert M, Flossdorf M, Rad R, Schmidt-Supprian M, Schneider G, Saur D. Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment. Nat Cancer 2022;3:318-36. [PMID: 35122074 DOI: 10.1038/s43018-021-00326-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
104 Zhou F, Lauretti E, di Meco A, Ciric B, Gonnella P, Zhang GX, Rostami A. Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity. Immunobiology 2013;218:1069-76. [PMID: 23587571 DOI: 10.1016/j.imbio.2013.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
105 Lee-Chang C, Bodogai M, Moritoh K, Chen X, Wersto R, Sen R, Young HA, Croft M, Ferrucci L, Biragyn A. Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers. J Immunol 2016;196:3385-97. [PMID: 26983789 DOI: 10.4049/jimmunol.1502034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
106 Cai S, Hu Z, Chen Y, Zhong J, Dong L. Potential roles of non-lymphocytic cells in the pathogenesis of IgG4-related disease. Front Immunol 2022;13:940581. [DOI: 10.3389/fimmu.2022.940581] [Reference Citation Analysis]
107 Li L, Yokoyama S, Han N, Hayakawa Y. Lac water extract inhibits IFN-γ signaling through JAK2-STAT1-IRF1 axis in human melanoma. RSC Adv 2018;8:21534-40. [DOI: 10.1039/c8ra02955e] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
108 Jena KK, Mehto S, Nath P, Chauhan NR, Sahu R, Dhar K, Das SK, Kolapalli SP, Murmu KC, Jain A, Krishna S, Sahoo BS, Chattopadhyay S, Rusten TE, Prasad P, Chauhan S, Chauhan S. Autoimmunity gene IRGM suppresses cGAS-STING and RIG-I-MAVS signaling to control interferon response. EMBO Rep 2020;21:e50051. [PMID: 32715615 DOI: 10.15252/embr.202050051] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
109 Kametani Y, Ohshima S, Kita YF, Shimada S, Kamiguchi H, Shiina T, Inoko H, Kulski JK, Ando A. Porcine MHC classical class I genes are coordinately expressed in superantigen-activated mononuclear cells. Vet Immunol Immunopathol 2012;148:252-9. [PMID: 22640570 DOI: 10.1016/j.vetimm.2012.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
110 Bartok O, Pataskar A, Nagel R, Laos M, Goldfarb E, Hayoun D, Levy R, Körner PR, Kreuger IZM, Champagne J, Zaal EA, Bleijerveld OB, Huang X, Kenski J, Wargo J, Brandis A, Levin Y, Mizrahi O, Alon M, Lebon S, Yang W, Nielsen MM, Stern-Ginossar N, Altelaar M, Berkers CR, Geiger T, Peeper DS, Olweus J, Samuels Y, Agami R. Anti-tumour immunity induces aberrant peptide presentation in melanoma. Nature 2021;590:332-7. [PMID: 33328638 DOI: 10.1038/s41586-020-03054-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
111 Sohn E, Yoon JW, Koo HJ, Park DW, Jeong YJ, Namkoong S, Han H, Kang SC. Immunomodulating Effects of Red Ginseng on the Regulation of Cytokine Release in vivo. Korean Journal of Plant Resources 2012;25:578-85. [DOI: 10.7732/kjpr.2012.25.5.578] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Angell TE, Lechner MG, Jang JK, LoPresti JS, Epstein AL. MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro. Clin Cancer Res 2014;20:6034-44. [PMID: 25294906 DOI: 10.1158/1078-0432.CCR-14-0879] [Cited by in Crossref: 74] [Cited by in F6Publishing: 44] [Article Influence: 9.3] [Reference Citation Analysis]
113 Khan MA, Malik A, Alzohairy MA, Alruwetei AM, Alhatlani BY, Rugaie OA, Khan A. Liposome-Mediated Delivery of MERS Antigen Induces Potent Humoral and Cell-Mediated Immune Response in Mice. Molecules 2022;27:403. [PMID: 35056718 DOI: 10.3390/molecules27020403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
114 Lorenzi S, Forloni M, Cifaldi L, Antonucci C, Citti A, Boldrini R, Pezzullo M, Castellano A, Russo V, van der Bruggen P, Giacomini P, Locatelli F, Fruci D. IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma. PLoS One 2012;7:e46928. [PMID: 23071666 DOI: 10.1371/journal.pone.0046928] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
115 Vincenti I, Merkler D. New advances in immune components mediating viral control in the CNS. Curr Opin Virol 2021;47:68-78. [PMID: 33636592 DOI: 10.1016/j.coviro.2021.02.001] [Reference Citation Analysis]
116 Stunnenberg M, van Hamme JL, Zijlstra-Willems EM, Gringhuis SI, Geijtenbeek TBH. Crosstalk between R848 and abortive HIV-1 RNA-induced signaling enhances antiviral immunity. J Leukoc Biol 2022. [PMID: 34982481 DOI: 10.1002/JLB.4A0721-365R] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Garay PA, McAllister AK. Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. Front Synaptic Neurosci. 2010;2:136. [PMID: 21423522 DOI: 10.3389/fnsyn.2010.00136] [Cited by in Crossref: 125] [Cited by in F6Publishing: 125] [Article Influence: 10.4] [Reference Citation Analysis]
118 Geoffroy K, Bourgeois-Daigneault MC. The pros and cons of interferons for oncolytic virotherapy. Cytokine Growth Factor Rev 2020;56:49-58. [PMID: 32694051 DOI: 10.1016/j.cytogfr.2020.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Allen H, Shraga-Heled N, Blumenfeld M, Dego-Ashto T, Fuchs-Telem D, Gilert A, Aberman Z, Ofir R. Human Placental-Derived Adherent Stromal Cells Co-Induced with TNF-α and IFN-γ Inhibit Triple-Negative Breast Cancer in Nude Mouse Xenograft Models. Sci Rep 2018;8:670. [PMID: 29330447 DOI: 10.1038/s41598-017-18428-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
120 Bukur J, Jasinski S, Seliger B. The role of classical and non-classical HLA class I antigens in human tumors. Semin Cancer Biol. 2012;22:350-358. [PMID: 22465194 DOI: 10.1016/j.semcancer.2012.03.003] [Cited by in Crossref: 104] [Cited by in F6Publishing: 95] [Article Influence: 10.4] [Reference Citation Analysis]
121 Luria-Pérez R, Candelaria PV, Daniels-Wells TR, Rodríguez JA, Helguera G, Penichet ML. Amino acid residues involved in the heparin-binding activity of murine IL-12 in the context of an antibody-cytokine fusion protein. Cytokine 2019;120:220-6. [PMID: 31121497 DOI: 10.1016/j.cyto.2019.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
122 Tu J, Xu H, Ma L, Li C, Qin W, Chen X, Yi M, Sun L, Liu B, Yuan X. Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells. Theranostics 2022;12:747-66. [PMID: 34976211 DOI: 10.7150/thno.65828] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
123 Hu Y, Burkard ME. Classes of therapeutics to amplify the immune response. Breast Cancer Res Treat 2021. [PMID: 34787761 DOI: 10.1007/s10549-021-06369-3] [Reference Citation Analysis]
124 Khazeei Tabari MA, Iranpanah A, Bahramsoltani R, Rahimi R. Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review. Molecules 2021;26:3900. [PMID: 34202374 DOI: 10.3390/molecules26133900] [Reference Citation Analysis]
125 Burke EE, Kodumudi K, Ramamoorthi G, Czerniecki BJ. Vaccine Therapies for Breast Cancer. Surgical Oncology Clinics of North America 2019;28:353-67. [DOI: 10.1016/j.soc.2019.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
126 Shao S, Tsoi LC, Sarkar MK, Xing X, Xue K, Uppala R, Berthier CC, Zeng C, Patrick M, Billi AC, Fullmer J, Beamer MA, Perez-White B, Getsios S, Schuler A, Voorhees JJ, Choi S, Harms P, Kahlenberg JM, Gudjonsson JE. IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus. Sci Transl Med 2019;11:eaav7561. [PMID: 31554739 DOI: 10.1126/scitranslmed.aav7561] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
127 Guo L, Xie H, Zhang Z, Wang Z, Peng S, Niu Y, Shang Z. Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer. Vaccines (Basel) 2021;9:786. [PMID: 34358202 DOI: 10.3390/vaccines9070786] [Reference Citation Analysis]
128 Frasca L, Lande R. Overlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functions. ScientificWorldJournal 2011;11:2071-90. [PMID: 22125457 DOI: 10.1100/2011/873895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
129 Brumfiel CM, Patel MH, Severson KJ, Zhang N, Li X, Quillen JK, Zunich SM, Branch EL, Nelson SA, Pittelkow MR, Mangold AR. Ruxolitinib cream in the treatment of cutaneous lichen planus: A prospective, open-label study. Journal of Investigative Dermatology 2022. [DOI: 10.1016/j.jid.2022.01.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Lichtenstern CR, Ngu RK, Shalapour S, Karin M. Immunotherapy, Inflammation and Colorectal Cancer. Cells 2020;9:E618. [PMID: 32143413 DOI: 10.3390/cells9030618] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
131 Rakshit S, Chandrasekar BS, Saha B, Victor ES, Majumdar S, Nandi D. Interferon-gamma induced cell death: Regulation and contributions of nitric oxide, cJun N-terminal kinase, reactive oxygen species and peroxynitrite. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2014;1843:2645-61. [DOI: 10.1016/j.bbamcr.2014.06.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
132 Bagati A, Kumar S, Jiang P, Pyrdol J, Zou AE, Godicelj A, Mathewson ND, Cartwright ANR, Cejas P, Brown M, Giobbie-Hurder A, Dillon D, Agudo J, Mittendorf EA, Liu XS, Wucherpfennig KW. Integrin αvβ6-TGFβ-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer. Cancer Cell 2021;39:54-67.e9. [PMID: 33385331 DOI: 10.1016/j.ccell.2020.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
133 Yu Z, Lu Y, Cao W, Aleem MT, Liu J, Luo J, Yan R, Xu L, Song X, Li X. Nano DNA Vaccine Encoding Toxoplasma gondii Histone Deacetylase SIR2 Enhanced Protective Immunity in Mice. Pharmaceutics 2021;13:1582. [PMID: 34683874 DOI: 10.3390/pharmaceutics13101582] [Reference Citation Analysis]
134 Petersen SH, Kua LF, Nakajima S, Yong WP, Kono K. Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer. Sci Rep 2021;11:12264. [PMID: 34112882 DOI: 10.1038/s41598-021-91603-7] [Reference Citation Analysis]
135 Allen CT, Judd NP, Bui JD, Uppaluri R. The clinical implications of antitumor immunity in head and neck cancer. The Laryngoscope 2012;122:144-57. [DOI: 10.1002/lary.21913] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
136 Speakman EA, Dambuza IM, Salazar F, Brown GD. T Cell Antifungal Immunity and the Role of C-Type Lectin Receptors. Trends Immunol. 2019;. [PMID: 31813764 DOI: 10.1016/j.it.2019.11.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
137 Imai T, Ishida H, Suzue K, Hirai M, Taniguchi T, Okada H, Suzuki T, Shimokawa C, Hisaeda H. CD8(+) T cell activation by murine erythroblasts infected with malaria parasites. Sci Rep 2013;3:1572. [PMID: 23535896 DOI: 10.1038/srep01572] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
138 Poat B, Hazari S, Chandra PK, Gunduz F, Balart LA, Alvarez X, Dash S. SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells. PLoS One 2010;5:e13117. [PMID: 20949125 DOI: 10.1371/journal.pone.0013117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
139 Zhao H, Wang J, Han Y, Huang Z, Ying J, Bi X, Zhao J, Fang Y, Zhou H, Zhou J, Li Z, Zhang Y, Yang X, Yan T, Wang L, Torbenson MS, Cai J. ARID2: a new tumor suppressor gene in hepatocellular carcinoma. Oncotarget 2011;2:886-91. [PMID: 22095441 DOI: 10.18632/oncotarget.355] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
140 Cleyle J, Hardy MP, Minati R, Courcelles M, Durette C, Lanoix J, Laverdure JP, Vincent K, Perreault C, Thibault P. Immunopeptidomic analyses of colorectal cancers with and without microsatellite instability. Mol Cell Proteomics 2022;21:100228. [PMID: 35367648 DOI: 10.1016/j.mcpro.2022.100228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
141 Ke M, Zhang Z, Xu B, Zhao S, Ding Y, Wu X, Wu R, Lv Y, Dong J. Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells. Int Immunopharmacol 2019;75:105824. [PMID: 31437792 DOI: 10.1016/j.intimp.2019.105824] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
142 Zhao X, Wangmo D, Robertson M, Subramanian S. Acquired Resistance to Immune Checkpoint Blockade Therapies. Cancers (Basel) 2020;12:E1161. [PMID: 32380703 DOI: 10.3390/cancers12051161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
143 Harel M, Ortenberg R, Varanasi SK, Mangalhara KC, Mardamshina M, Markovits E, Baruch EN, Tripple V, Arama-Chayoth M, Greenberg E, Shenoy A, Ayasun R, Knafo N, Xu S, Anafi L, Yanovich-Arad G, Barnabas GD, Ashkenazi S, Besser MJ, Schachter J, Bosenberg M, Shadel GS, Barshack I, Kaech SM, Markel G, Geiger T. Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence. Cell 2019;179:236-250.e18. [PMID: 31495571 DOI: 10.1016/j.cell.2019.08.012] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 24.7] [Reference Citation Analysis]
144 Zhou F, Chen J, Zhao KN. Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes. J Gen Virol 2013;94:2504-14. [PMID: 23956301 DOI: 10.1099/vir.0.054486-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
145 Lybaert L, Vermaelen K, De Geest BG, Nuhn L. Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity. Journal of Controlled Release 2018;289:125-45. [DOI: 10.1016/j.jconrel.2018.09.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
146 Chen YC, He XL, Qi L, Shi W, Yuan LW, Huang MY, Xu YL, Chen X, Gu L, Zhang LL, Lu JJ. Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells. Biochem Pharmacol 2022;:114940. [PMID: 35120895 DOI: 10.1016/j.bcp.2022.114940] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Xu N, Lei H, Li X, Wang Q, Liu M, Wang M. Protective effects of Ginger Essential Oil (GEO) against chemically-induced cutaneous inflammation. Food Sci Technol 2019;39:371-7. [DOI: 10.1590/fst.14318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
148 Demel UM, Böger M, Yousefian S, Grunert C, Zhang L, Hotz PW, Gottschlich A, Köse H, Isaakidis K, Vonficht D, Grünschläger F, Rohleder E, Wagner K, Dönig J, Igl V, Brzezicha B, Baumgartner F, Habringer S, Löber J, Chapuy B, Weidinger C, Kobold S, Haas S, Busse AB, Müller S, Wirth M, Schick M, Keller U. Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer. Journal of Clinical Investigation 2022;132:e152383. [DOI: 10.1172/jci152383] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Ito G, Tanaka H, Ohira M, Yoshii M, Muguruma K, Kubo N, Yashiro M, Yamada N, Maeda K, Sawada T, Hirakawa K. Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I. Exp Ther Med 2012;3:925-30. [PMID: 22969994 DOI: 10.3892/etm.2012.537] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
150 Rastall DPW, Alyaquob FS, O'Connell P, Pepelyayeva Y, Peters D, Godbehere-Roosa S, Pereira-Hicks C, Aldhamen YA, Amalfitano A. Mice expressing human ERAP1 variants associated with ankylosing spondylitis have altered T-cell repertoires and NK cell functions, as well as increased in utero and perinatal mortality. Int Immunol 2017;29:277-89. [PMID: 28814066 DOI: 10.1093/intimm/dxx035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
151 Wang S, Wang Y, Sun X, Zhang Z, Liu T, Gadahi JA, Hassan IA, Xu L, Yan R, Song X, Li X. Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha. BMC Infect Dis 2015;15:448. [PMID: 26497908 DOI: 10.1186/s12879-015-1220-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
152 Kelly KJ, Liu Y, Zhang J, Goswami C, Lin H, Dominguez JH. Comprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways. Physiol Genomics 2013;45:710-9. [PMID: 23757392 DOI: 10.1152/physiolgenomics.00028.2013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
153 Angelidis I, Simon LM, Fernandez IE, Strunz M, Mayr CH, Greiffo FR, Tsitsiridis G, Ansari M, Graf E, Strom TM, Nagendran M, Desai T, Eickelberg O, Mann M, Theis FJ, Schiller HB. An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics. Nat Commun 2019;10:963. [PMID: 30814501 DOI: 10.1038/s41467-019-08831-9] [Cited by in Crossref: 162] [Cited by in F6Publishing: 120] [Article Influence: 54.0] [Reference Citation Analysis]
154 Padariya M, Kote S, Mayordomo M, Dapic I, Alfaro J, Hupp T, Fahraeus R, Kalathiya U. Structural determinants of peptide-dependent TAP1-TAP2 transit passage targeted by viral proteins and altered by cancer-associated mutations. Comput Struct Biotechnol J 2021;19:5072-91. [PMID: 34589184 DOI: 10.1016/j.csbj.2021.09.006] [Reference Citation Analysis]
155 McCaw TR, Goel N, Brooke DJ, Katre AA, Londoño AI, Smith HJ, Randall TD, Arend RC. Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer. Cancer Med 2021;10:709-17. [PMID: 33369199 DOI: 10.1002/cam4.3337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
156 Wu Z, Tang Z, Shang M, Zhao L, Zhou L, Kong X, Lin Z, Sun H, Chen T, Xu J, Li X, Huang Y, Yu X. Comparative analysis of immune effects in mice model: Clonorchis sinensis cysteine protease generated from recombinant Escherichia coli and Bacillus subtilis spores. Parasitol Res 2017;116:1811-22. [PMID: 28502017 DOI: 10.1007/s00436-017-5445-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
157 Slotta-huspenina J, Schwamborn K, Steiger K, Simon R, Kirchhoff FP, Büchler JW, Fiedler J, Retz M, Nawroth R, Ritschel C, Gschwend JE, Horn T. MHC I Expression Predicts Response to Checkpoint Inhibitors in Metastatic Urothelial Carcinoma but Lacks Prognostic Value in Localized Disease. BLC 2022;1:1-8. [DOI: 10.3233/blc-211604] [Reference Citation Analysis]
158 Wang Q, Shen X, Chen G, Du J. Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. Cancers (Basel) 2022;14:2928. [PMID: 35740594 DOI: 10.3390/cancers14122928] [Reference Citation Analysis]
159 Khetsuphan T, Chaisri U, Dechkhajorn W, Benjathummarak S, Dekumyoy P, Ampawong S, Viriyavejakul P, Maneerat Y. Effects of Gnathostoma spinigerum infective stage larva excretory-secretory products on NK cells in peripheral blood mononuclear cell culture: focused on expressions of IFN-γ and killer cell lectin-like receptors. Parasitol Res 2020;119:1011-21. [PMID: 31932913 DOI: 10.1007/s00436-019-06593-3] [Reference Citation Analysis]
160 Hosseini-Tabatabaei A, Jalili RB, Li Y, Kilani RT, Moeen Rezakhanlou A, Ghahary A. Mechanism underlying defective interferon gamma-induced IDO expression in non-obese diabetic mouse fibroblasts. PLoS One 2012;7:e37747. [PMID: 22662207 DOI: 10.1371/journal.pone.0037747] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
161 Zhou F, Zhang GX, Rostami A. Apoptotic cell-treated dendritic cells induce immune tolerance by specifically inhibiting development of CD4⁺ effector memory T cells. Immunol Res 2016;64:73-81. [PMID: 26111522 DOI: 10.1007/s12026-015-8676-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
162 Silva M, Silva Z, Marques G, Ferro T, Gonçalves M, Monteiro M, van Vliet SJ, Mohr E, Lino AC, Fernandes AR, Lima FA, van Kooyk Y, Matos T, Tadokoro CE, Videira PA. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses. Oncotarget 2016;7:41053-66. [PMID: 27203391 DOI: 10.18632/oncotarget.9419] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
163 Cox SN, Sallustio F, Serino G, Loverre A, Pesce F, Gigante M, Zaza G, Stifanelli PF, Ancona N, Schena FP. Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy. Kidney Int 2012;82:548-60. [PMID: 22572859 DOI: 10.1038/ki.2012.147] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
164 Campoli M, Ferrone S. HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition. Semin Immunopathol. 2011;33:321-334. [PMID: 21523560 DOI: 10.1007/s00281-011-0270-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
165 Zhou F, Ciric B, Zhang GX, Rostami A. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis. Clin Exp Immunol 2014;178:447-58. [PMID: 25138204 DOI: 10.1111/cei.12440] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
166 Guo W, Wang Y, Yang M, Wang Z, Wang Y, Chaurasia S, Wu Z, Zhang M, Yadav GS, Rathod S, Concha-Benavente F, Fernandez C, Li S, Xie W, Ferris RL, Kammula US, Lu B, Yang D. LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance. Sci Adv 2021;7:eabb3555. [PMID: 33568470 DOI: 10.1126/sciadv.abb3555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
167 Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, Mencarini J, Caporale R, Peruzzi B, Antonelli A, Trotta M, Zammarchi L, Ciani L, Gori L, Lazzeri C, Matucci A, Vultaggio A, Rossi O, Almerigogna F, Parronchi P, Fontanari P, Lavorini F, Peris A, Rossolini GM, Bartoloni A, Romagnani S, Liotta F, Annunziato F, Cosmi L. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020;130:4694-4703. [PMID: 32463803 DOI: 10.1172/jci138554] [Cited by in Crossref: 166] [Cited by in F6Publishing: 129] [Article Influence: 83.0] [Reference Citation Analysis]
168 Huot N, Rascle P, Petitdemange C, Contreras V, Stürzel CM, Baquero E, Harper JL, Passaes C, Legendre R, Varet H, Madec Y, Sauermann U, Stahl-Hennig C, Nattermann J, Saez-Cirion A, Le Grand R, Keith Reeves R, Paiardini M, Kirchhoff F, Jacquelin B, Müller-Trutwin M. SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity. Nat Commun 2021;12:1282. [PMID: 33627642 DOI: 10.1038/s41467-021-21402-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
169 Mansurov A, Ishihara J, Hosseinchi P, Potin L, Marchell TM, Ishihara A, Williford JM, Alpar AT, Raczy MM, Gray LT, Swartz MA, Hubbell JA. Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours. Nat Biomed Eng 2020;4:531-43. [PMID: 32284554 DOI: 10.1038/s41551-020-0549-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 20.5] [Reference Citation Analysis]
170 Esser-Nobis K, Schmidt J, Nitschke K, Neumann-Haefelin C, Thimme R, Lohmann V. The cyclophilin-inhibitor alisporivir stimulates antigen presentation thereby promoting antigen-specific CD8(+) T cell activation. J Hepatol 2016;64:1305-14. [PMID: 26921685 DOI: 10.1016/j.jhep.2016.02.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
171 Siddique R, Mehmood MH, Haris M, Saleem A, Chaudhry Z. Promising role of polymeric nanoparticles in the treatment of rheumatoid arthritis. Inflammopharmacology 2022. [PMID: 35524837 DOI: 10.1007/s10787-022-00997-x] [Reference Citation Analysis]
172 Komov L, Melamed Kadosh D, Barnea E, Admon A. The Effect of Interferons on Presentation of Defective Ribosomal Products as HLA Peptides. Mol Cell Proteomics 2021;20:100105. [PMID: 34087483 DOI: 10.1016/j.mcpro.2021.100105] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
173 Yin L, Liu X, Hu D, Luo Y, Zhang G, Liu P. Swine Enteric Coronaviruses (PEDV, TGEV, and PDCoV) Induce Divergent Interferon-Stimulated Gene Responses and Antigen Presentation in Porcine Intestinal Enteroids. Front Immunol 2022;12:826882. [DOI: 10.3389/fimmu.2021.826882] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
174 Sabbatino F, Marra A, Liguori L, Scognamiglio G, Fusciello C, Botti G, Ferrone S, Pepe S. Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature. J Immunother Cancer 2018;6:126. [PMID: 30458852 DOI: 10.1186/s40425-018-0439-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
175 Oya K, Nakamura Y, Zhenjie Z, Tanaka R, Okiyama N, Ichimura Y, Ishitsuka Y, Saito A, Kubota N, Watanabe R, Tahara H, Fujimoto M, Fujisawa Y. Combination Treatment of Topical Imiquimod Plus Anti-PD-1 Antibody Exerts Significantly Potent Antitumor Effect. Cancers (Basel) 2021;13:3948. [PMID: 34439104 DOI: 10.3390/cancers13163948] [Reference Citation Analysis]
176 Villarino N, Schmidt NW. CD8+ T Cell Responses to Plasmodium and Intracellular Parasites. Curr Immunol Rev 2013;9:169-78. [PMID: 24741372 DOI: 10.2174/1573395509666131126232327] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
177 Mina M, Boldrini R, Citti A, Romania P, D'Alicandro V, De Ioris M, Castellano A, Furlanello C, Locatelli F, Fruci D. Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma. Oncoimmunology 2015;4:e1019981. [PMID: 26405592 DOI: 10.1080/2162402X.2015.1019981] [Cited by in Crossref: 66] [Cited by in F6Publishing: 47] [Article Influence: 9.4] [Reference Citation Analysis]
178 Wei H, Hongya P, Linlin J, Mujiang A, Kuijie W, Duohong Z, Qingang H, Zhiyuan Z. IFN-γ enhances the anti-tumour immune response of dendritic cells against oral squamous cell carcinoma. Archives of Oral Biology 2011;56:891-8. [DOI: 10.1016/j.archoralbio.2011.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
179 Gotthardt D, Trifinopoulos J, Sexl V, Putz EM. JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation. Front Immunol 2019;10:2590. [PMID: 31781102 DOI: 10.3389/fimmu.2019.02590] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
180 Luo N, Formisano L, Gonzalez-Ericsson PI, Sanchez V, Dean PT, Opalenik SR, Sanders ME, Cook RS, Arteaga CL, Johnson DB, Balko JM. Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2. Oncoimmunology 2018;7:e1438106. [PMID: 29872580 DOI: 10.1080/2162402X.2018.1438106] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
181 Wang X, Wu B, Yan Z, Wang G, Chen S, Zeng J, Tao F, Xu B, Ke H, Li M. Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades. Front Oncol 2021;11:650122. [PMID: 34123798 DOI: 10.3389/fonc.2021.650122] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Hou J, Chen SN, Gan Z, Li N, Huang L, Huo HJ, Yang YC, Lu Y, Yin Z, Nie P. In Primitive Zebrafish, MHC Class II Expression Is Regulated by IFN-γ, IRF1, and Two Forms of CIITA. J I . [DOI: 10.4049/jimmunol.1801480] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
183 Marijt KA, Sluijter M, Blijleven L, Tolmeijer SH, Scheeren FA, van der Burg SH, van Hall T. Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling. J Immunother Cancer 2019;7:152. [PMID: 31196219 DOI: 10.1186/s40425-019-0627-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 11.7] [Reference Citation Analysis]
184 Murtadha AH, Azahar IIM, Sharudin NA, Has ATC, Mokhtar NF. Influence of nNav1.5 on MHC class I expression in breast cancer. J Biosci 2021;46. [DOI: 10.1007/s12038-021-00196-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]